Search results
Results from the WOW.Com Content Network
San Diego Business Journal; San Diego City Beat; San Diego Jewish Journal; San Diego Magazine; San Diego Reader; San Diego Union-Tribune (acquired by Tribune Publishing) Times of San Diego; Retail. Le Travel Store (closed) Mor Furniture; Petco; PriceSmart; Sports. BikeBandit; BMC USA; Competitor Group, Inc. Ellsworth Handcrafted Bicycles ...
2021: In March, the company announced it would acquire Five Prime Therapeutics and its lead candidate, bemarituzumab, for $1.9 billion. [93] [94] [95] In the same month, Amgen acquired Rodeo Therapeutics for $720 million. [96] [97] The FDA approved Amgen's Lumakras in May for treatment of patients with KRAS-G12C-mutated non-small cell lung ...
The company’s name comes from the Italian word for “targeted” (Mirati). Mirati Therapeutics is traded on the Nasdaq [6] under the ticker symbol MRTX. [7] It joined the exchange in 2013. [8] In October 2023, Bristol Myers Squibb agreed to acquire the company in an all-cash deal worth $4.8 billion, and an additional $1 billion in milestone ...
This file contains additional information, probably added from the digital camera or scanner used to create or digitize it. If the file has been modified from its original state, some details may not fully reflect the modified file.
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer.
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. [2]
At the time, the company had five drugs in development and was running two in human trials. [22] The company had a subsequent round of stock offering in May 2007 which raised US$102 million. [23] In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics. [24]
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs).